---
title: "Adial Pharmaceuticals (ADIL.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ADIL.US/norm.md"
symbol: "ADIL.US"
name: "Adial Pharmaceuticals"
parent: "https://longbridge.com/en/quote/ADIL.US.md"
datetime: "2026-05-21T05:55:33.324Z"
locales:
  - [en](https://longbridge.com/en/quote/ADIL.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ADIL.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ADIL.US/norm.md)
---

# Adial Pharmaceuticals (ADIL.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.48 | -1.82 | -2.02 | -4.61 | -8.52 |
| ROE | -179.89% | -163.26% | -142.13% | -203.03% | -287.83% |
| Revenue | - | - | - | - | - |
| Net income | -2.02M | -2.00M | -1.79M | -1.96M | -2.23M |
| Operating income | -2.00M | -1.89M | -1.76M | -1.88M | -2.27M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 5.23M | 6.67M | 5.66M | 6.80M | 3.45M |
| Leverage | 1.41 | 1.26 | 1.26 | 1.22 | 1.62 |
| BVPS | 2.46 | 4.75 | 4.72 | 6.49 | 8.00 |
| Turnover | - | - | - | - | - |
| Cash & STI | 4.58M | 5.88M | 4.61M | 5.91M | 2.37M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | - | - |
| Net debt | -4.58M | -5.88M | -4.61M | -5.91M | -2.37M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -1.61M | -1.32M | -1.83M | -1.75M | -1.59M |
| Investing CF | - | 0.0000 | 0.0000 | 0.0000 | 150000.00 |
| Financing CF | 315284.00 | 2.60M | 524682.00 | 5.30M | 50648.00 |
| Free CF | -1.06M | -660154.00 | -1.26M | -1.07M | -786740.00 |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |